← Browse by Condition
Medical Condition

spinocerebellar ataxia

Total Trials
3
Recruiting Now
3
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for spinocerebellar ataxia sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing

Frequently Asked Questions — spinocerebellar ataxia Clinical Trials

How many clinical trials are currently recruiting for spinocerebellar ataxia?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for spinocerebellar ataxia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for spinocerebellar ataxia?
spinocerebellar ataxia research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a spinocerebellar ataxia clinical trial?
Eligibility criteria for spinocerebellar ataxia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Ataxia Study Group 1 trial
ALPS Biotech CO. LTD 1 trial
University Hospital, Montpellier 1 trial

Recruiting Clinical Trials

NCT02440763
Recruiting

The EUROSCA Natural History Study

Enrollment
400 pts
Location
Austria, Belgium, Fr...
Sponsor
Ataxia Study Group
View Trial →
NCT06633003
Recruiting

Effects of Oral Administration of Antrodia Cinnamomea Products for Clinical Symptoms in Spinocerebellar Ataxia Patients

Enrollment
60 pts
Location
Taiwan
Sponsor
ALPS Biotech CO. LTD
View Trial →
NCT07019558
Recruiting

Ophthalmological Disorders in Dominant Spinal-cerebellar Ataxias

Enrollment
60 pts
Location
France
Sponsor
University Hospital, Montpelli...
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology